Viatris, Kindeva Drug Delivery debut generic SymbicortBreyna, a drug-device combination product, is indicated for certain patients with asthma or chronic obstructive pulmonary disease. Camber launches generic Daptomycin for injection, generic CubicinDaptomcycin for injection is a lipopeptide antibacterial indicated for treating complicated skin and skin structure infections in adult and pediatric patients. Endo debuts bivalirudin injection in ready-to-use vials Bivalirudin injection is the only ready-to-use liquid format of bivalirudin on the market in the United States. Aurobindo receives FDA permission for generic Cortef Generic Cortef is indicated for various diseases and disorders. Xiromed intros generic Akovaz Generic Akovaz is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. Sandoz to build biosimilar technical development center in Slovenia Sandoz will invest roughly $90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia, by 2026. Aurobindo receives FDA OK for 2 generics Aurobindo has received the FDA's nod for generic Steglatro and generic Otezla. Teva, Alvotech expand biosimilars partnership agreement Teva will exclusively commercialize two new biosimilar candidates and two line extensions of current biosimilars in the U.S., developed and manufactured by Alvotech. Camber intros generic Noxafil The tablets are indicated for the prophylaxis of invasive Aspergillus and Candida infections in severely immunocompromised patients. Natco obtains FDA nod for generic Lonsurf Generic Lonsurf is indicated primarily for the treatment of colorectal cancer. First Previous 50 51 52 53 54 Next Last
